HUP9901630A2 - Új indol-2,3-dion-3-oxim-származékok - Google Patents
Új indol-2,3-dion-3-oxim-származékokInfo
- Publication number
- HUP9901630A2 HUP9901630A2 HU9901630A HUP9901630A HUP9901630A2 HU P9901630 A2 HUP9901630 A2 HU P9901630A2 HU 9901630 A HU9901630 A HU 9901630A HU P9901630 A HUP9901630 A HU P9901630A HU P9901630 A2 HUP9901630 A2 HU P9901630A2
- Authority
- HU
- Hungary
- Prior art keywords
- het
- alkyl
- dione
- ring
- formula
- Prior art date
Links
- LNMAXZZQNSPQSR-UHFFFAOYSA-N 3-(hydroxyamino)indol-2-one Chemical class C1=CC=CC2=NC(=O)C(NO)=C21 LNMAXZZQNSPQSR-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- NGXLTYPELAIUHE-UHFFFAOYSA-N 2-(hydroxyamino)indol-3-one Chemical class C1=CC=C2C(=O)C(NO)=NC2=C1 NGXLTYPELAIUHE-UHFFFAOYSA-N 0.000 abstract 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 abstract 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
- 125000005092 alkenyloxycarbonyl group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000005225 alkynyloxycarbonyl group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 abstract 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000005170 cycloalkyloxycarbonyl group Chemical group 0.000 abstract 1
- 229930195712 glutamate Natural products 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- -1 hydroxy, carboxyl Chemical group 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000006850 spacer group Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
A találmány új indől-2,3-diőn-őximőkra vőnatkőzik, amelyek az ingerlőaminősavak, pl. glűtamát hatását antagőnizálják. A vegyületek az (I)képlettel jellemezhetők, ahől R1 jelentése hidrőgénatőm, alkil- vagybenzilcsőpőrt; R3 jelentése Het, vagy a (II) képlettel, ahől Hetjelentése telített vagy telítetlen 4-7 tagú mőnőciklűsős vagyheterőciklűsős gyűrű, R31, R32, R33 közül legalább az egyik hidrőgén,alkil- vagy hidrőxialkil- és a másik (CH2)nR34 csőpőrt, ahől R34jelentése hidrőxil-, karbőxil-, alkőxi-karbőnil-, alkenil-őxi-karbőnil-, alkinil-őxi-karbőnil-, ciklőalkőxi-karbőnil-, ciklőalkil-alkőxi-karbőnil-, aril-őxi-karbőnil-, aralkőxi-karbőnil-, CONR35R36csőpőrt vagy Het, ahől n értéke 0, 1, 2 vagy 3; és R5 jelentésefenil-, naftil-, tienil- vagy piridilcsőpőrt, melyek mindszűbsztitűálva lehetnek. A jelentése 5-7 tagú, benzőlgyűrűvelfűziőnált gyűrű az a és b helyzetben, és amelyeket az alábbi kétértékűcsőpőrtők képeznek: a-NR6-CH2-CH2-b, a-CH2-NR6-CH2-b, a-CH2-CH2-NR6-b,a-NR6-CH2-CH2-CH2-b, a-CH2-NR6-CH2-CH2-b, a-CH2-CH2-NR6-CH2-b, a-CH2-CH2-CH2-NR6-b, a-NR6-CH2-CH2-CH2-CH2-b, a-CH2-NR6-CH2-CH2-CH2-b, a-CH2-CH2-NR6-CH2-CH2-b, a-CH2-CH2-CH2-NR6-CH2-b vagy CH2-CH2-CH2-CH2-NR6-b, ahől R6 jelentése hidrőgénatőm, alkil- vagy CH2CH2OH csőpőrt,vagy gyógyászatilag elfőgadható sója. ŕ
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK106996 | 1996-10-01 | ||
| DK127796 | 1996-11-13 | ||
| PCT/DK1997/000418 WO1998014447A1 (en) | 1996-10-01 | 1997-10-01 | Novel indole-2,3-dione-3-oxime derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HUP9901630A2 true HUP9901630A2 (hu) | 1999-08-30 |
| HUP9901630A3 HUP9901630A3 (en) | 2001-11-28 |
| HU225145B1 HU225145B1 (en) | 2006-07-28 |
Family
ID=26065167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9901630A HU225145B1 (en) | 1996-10-01 | 1997-10-01 | Indole-2,3-dione-3-oxime derivatives as antagonists of excitatory amino acids, preparation and use thereof |
Country Status (29)
| Country | Link |
|---|---|
| US (3) | USRE38200E1 (hu) |
| EP (1) | EP0869958B1 (hu) |
| JP (1) | JP3319762B2 (hu) |
| KR (1) | KR100492052B1 (hu) |
| CN (1) | CN1093859C (hu) |
| AT (1) | ATE286052T1 (hu) |
| AU (1) | AU716435B2 (hu) |
| BG (1) | BG63874B1 (hu) |
| BR (1) | BR9706765A (hu) |
| CA (1) | CA2238410C (hu) |
| CZ (1) | CZ297938B6 (hu) |
| DE (1) | DE69732090T2 (hu) |
| DK (1) | DK0869958T3 (hu) |
| EE (1) | EE9800144A (hu) |
| ES (1) | ES2235253T3 (hu) |
| HK (1) | HK1017682A1 (hu) |
| HU (1) | HU225145B1 (hu) |
| IL (1) | IL124563A (hu) |
| IS (1) | IS2123B (hu) |
| NO (1) | NO310722B1 (hu) |
| NZ (1) | NZ330456A (hu) |
| PL (1) | PL193041B1 (hu) |
| PT (1) | PT869958E (hu) |
| RU (1) | RU2190612C2 (hu) |
| SI (1) | SI0869958T1 (hu) |
| SK (1) | SK282729B6 (hu) |
| TR (1) | TR199800956T1 (hu) |
| UA (1) | UA54403C2 (hu) |
| WO (1) | WO1998014447A1 (hu) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA54403C2 (uk) * | 1996-10-01 | 2003-03-17 | Н'Юросерч А/С | Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму |
| DE69922936T2 (de) | 1998-03-31 | 2005-12-08 | Neurosearch A/S | Verwendung von indol-2,3-dione-3-oximderivate als ampa-antagonisten |
| DE60041399D1 (de) | 1999-05-19 | 2009-03-05 | Painceptor Pharma Corp | Hemmer der protonenabhängigen kationenkanäle und deren verwendung in der behandlung von ischemiebedingten erkrankungen |
| AU781067B2 (en) * | 2000-01-24 | 2005-05-05 | Neurosearch A/S | Isatine derivatives with neurotrophic activity |
| IT1318636B1 (it) * | 2000-07-21 | 2003-08-27 | Roberto Pellicciari | Derivati dell'acido 2- o 3- tenoico ad attivita' antagonista deirecettori del glutammato. |
| EP1361878A1 (en) * | 2001-02-15 | 2003-11-19 | Neurosearch A/S | Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity |
| JP2005522408A (ja) | 2001-07-13 | 2005-07-28 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | ５−ＨＴ受容体リガントとしてのヘキサヒドロアゼピノ（４，５−ｇ）インドールおよびインドリン |
| CN1296372C (zh) * | 2002-08-22 | 2007-01-24 | 神经研究公司 | 制备吲哚－2,3－二酮－3－肟衍生物的对映异构体的方法 |
| GB0507298D0 (en) | 2005-04-11 | 2005-05-18 | Novartis Ag | Organic compounds |
| CN101346375B (zh) | 2005-11-23 | 2013-04-10 | 阿罗斯药物有限责任公司 | 调节门离子通道用组合物和方法 |
| US20080021034A1 (en) * | 2006-04-10 | 2008-01-24 | Painceptor Pharma Corporation | Compositions and methods for modulating gated ion channels |
| WO2007115409A1 (en) * | 2006-04-10 | 2007-10-18 | Painceptor Pharma Corporation | Compositions and methods for modulating gated ion channels |
| WO2008031831A2 (en) * | 2006-09-12 | 2008-03-20 | Neurosearch A/S | Pharmaceutical compositions comprising combinations of an ampa/kainate antagonistic compound and an inhibitor of a multidrug resistance protein |
| US20080108622A1 (en) * | 2006-10-19 | 2008-05-08 | Eisenach James C | Combination therapy for the treatment of pain |
| US20080108603A1 (en) * | 2006-10-19 | 2008-05-08 | Eisenach James C | Combination therapy for the treatment of pain |
| WO2010104324A2 (ko) * | 2009-03-10 | 2010-09-16 | 한국과학기술연구원 | 베타-아밀로이드 집적체 및 피브릴에 우수한 결합 친화도를 가지는 할로겐화 이소인돌론 화합물, 및 이의 제조 방법 및 용도 |
| CN102653538A (zh) * | 2011-03-04 | 2012-09-05 | 爱斯医药科技(南京)有限公司 | Spd-502的制备方法 |
| US10604484B2 (en) | 2015-04-29 | 2020-03-31 | Janssen Pharmaceutica Nv | Indolone compounds and their use as AMPA receptor modulators |
| EP3288940B9 (en) | 2015-04-29 | 2021-07-21 | Janssen Pharmaceutica NV | Azabenzimidazoles and their use as ampa receptor modulators |
| US10513523B2 (en) | 2015-04-29 | 2019-12-24 | Janssen Pharmaceutica Nv | Imidazopyrazines and pyrazolopyrimidines and their use as AMPA receptor modulators |
| JP6804469B2 (ja) | 2015-04-29 | 2020-12-23 | ヤンセン ファーマシューティカ エヌ．ベー． | ベンゾイミダゾロン及びベンゾチアゾロン化合物並びにａｍｐａ受容体調節因子としてのそれらの使用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9204914A (es) * | 1991-08-28 | 1993-07-01 | Frank Watjen | Nuevos derivados de isatinoxima, metodo para su preparacion y composicion farmaceutica que los comprende. |
| US5721230A (en) | 1993-05-10 | 1998-02-24 | Hoffmann-La Roche Inc. | Substituted pyrroles |
| JP3439215B2 (ja) * | 1993-05-13 | 2003-08-25 | ノイロサーチ アクティーゼルスカブ | Ａｍｐａ拮抗薬およびそれを用いての治療方法 |
| DK81593D0 (da) * | 1993-07-07 | 1993-07-07 | Neurosearch As | Nye isatinoximderivater, deres fremstilling og anvendelse |
| JP3164372B2 (ja) * | 1994-09-14 | 2001-05-08 | ノイロサーチ アクティーゼルスカブ | 融合インドール及びキノキサリン誘導体、その製造および使用 |
| JP3164371B2 (ja) * | 1994-09-14 | 2001-05-08 | ノイロサーチ アクティーゼルスカブ | インドール−２，３−ジオン−３−オキシム誘導体、その製造および使用 |
| UA54403C2 (uk) * | 1996-10-01 | 2003-03-17 | Н'Юросерч А/С | Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму |
-
1997
- 1997-01-10 UA UA98052752A patent/UA54403C2/uk unknown
- 1997-10-01 PT PT97941880T patent/PT869958E/pt unknown
- 1997-10-01 EE EE9800144A patent/EE9800144A/xx unknown
- 1997-10-01 RU RU98112237/04A patent/RU2190612C2/ru not_active IP Right Cessation
- 1997-10-01 US US09/956,892 patent/USRE38200E1/en not_active Expired - Fee Related
- 1997-10-01 WO PCT/DK1997/000418 patent/WO1998014447A1/en active IP Right Grant
- 1997-10-01 US US09/077,554 patent/US6124285A/en not_active Expired - Lifetime
- 1997-10-01 CZ CZ0160698A patent/CZ297938B6/cs not_active IP Right Cessation
- 1997-10-01 NZ NZ330456A patent/NZ330456A/en unknown
- 1997-10-01 PL PL327073A patent/PL193041B1/pl not_active IP Right Cessation
- 1997-10-01 SK SK676-98A patent/SK282729B6/sk not_active IP Right Cessation
- 1997-10-01 JP JP51615898A patent/JP3319762B2/ja not_active Expired - Fee Related
- 1997-10-01 AT AT97941880T patent/ATE286052T1/de not_active IP Right Cessation
- 1997-10-01 CA CA002238410A patent/CA2238410C/en not_active Expired - Fee Related
- 1997-10-01 CN CN97191602A patent/CN1093859C/zh not_active Expired - Fee Related
- 1997-10-01 EP EP97941880A patent/EP0869958B1/en not_active Expired - Lifetime
- 1997-10-01 DE DE69732090T patent/DE69732090T2/de not_active Expired - Lifetime
- 1997-10-01 SI SI9730698T patent/SI0869958T1/xx unknown
- 1997-10-01 IL IL12456397A patent/IL124563A/xx not_active IP Right Cessation
- 1997-10-01 ES ES97941880T patent/ES2235253T3/es not_active Expired - Lifetime
- 1997-10-01 BR BR9706765-2A patent/BR9706765A/pt not_active Application Discontinuation
- 1997-10-01 TR TR1998/00956T patent/TR199800956T1/xx unknown
- 1997-10-01 KR KR10-1998-0704103A patent/KR100492052B1/ko not_active IP Right Cessation
- 1997-10-01 HU HU9901630A patent/HU225145B1/hu not_active IP Right Cessation
- 1997-10-01 DK DK97941880T patent/DK0869958T3/da active
- 1997-10-01 AU AU43768/97A patent/AU716435B2/en not_active Ceased
-
1998
- 1998-05-18 IS IS4748A patent/IS2123B/xx unknown
- 1998-05-26 BG BG102489A patent/BG63874B1/bg unknown
- 1998-05-29 NO NO19982466A patent/NO310722B1/no not_active IP Right Cessation
-
1999
- 1999-06-30 HK HK99102769A patent/HK1017682A1/xx not_active IP Right Cessation
-
2000
- 2000-05-31 US US09/584,117 patent/US6693111B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9901630A2 (hu) | Új indol-2,3-dion-3-oxim-származékok | |
| AU8772691A (en) | New compounds | |
| DK0977741T3 (da) | Substituerede phenylderivater, deres fremstilling og anvendelse | |
| HUP0003731A2 (hu) | 4-Bróm- vagy 4-jód-fenil-amino-benzhidroxámsav-származékok és ilyen vegyületek MEK gátlóként való alkalmazása | |
| NO20003133D0 (no) | Anilidderivater, fremstilling og anvendelse derav | |
| FI952709A (fi) | 1,4-bentsodiatsepiinijohdannaisia ja niiden käyttö cck-modulaattoreina | |
| ATE156804T1 (de) | Ethanolamin-derivate mit sympathomimetischer und anti-pollakiuria wirkung | |
| ATE251153T1 (de) | Neue thiazol-derivate mit phosphodiesterase inhibierender wirkung | |
| FI954965A (fi) | AMPA-antagonisteja ja hoitomenetelmä, jossa niitä käytetään | |
| FI913614A (fi) | Menetelmä terapeuttisesti käyttökelpoisten N-sulfonyyli-indoliinijohdannaisten valmistamiseksi | |
| GB1424450A (en) | Isoindoline intermediates | |
| ES450897A1 (es) | Procedimiento para la preparacion de n-(r-tetrahidrofurfu- ril)-noroximorfona y n-(s-tetrahidrofurfuril)-noroximorfona. | |
| GB1423087A (en) | Benzothiadiazines process for their preparation and applications thereof | |
| GB1324423A (en) | Salicylamide derivatives | |
| ES471208A1 (es) | Procedimiento para la preparacion de nuevos derivados con- densados de pirimidina | |
| DK0687257T3 (da) | 4-amino-2-(hetero)aryl-butanamider anvendelige som 5HT1A-antagonister | |
| ES455507A1 (es) | Procedimiento para preparar derivados de dipeptido. | |
| SE7509884L (sv) | Fenyletylaminderivat | |
| SU1783774A1 (ru) | Натриевая соль n-(3-хлорбутен-2-ил)антраниловой кислоты, проявляющая противовоспалительную и анальгетическую активность | |
| HUP9701109A2 (hu) | Ammónium-oxazol és amino-oxazolium intermedierek, eljárás előállításukra és ezek alkalmazása inszekticid hatású aril-pirrolok előállítására | |
| HUP9902606A2 (hu) | Mátrix metalloproteináz inhibitorok | |
| ES455874A1 (es) | Un procedimiento para la preparacion de nuevas azetidlnonas y derivados de las mismas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of definitive patent protection due to non-payment of fees |